Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Krystexxa

PharmaCompass

01

Brand Name : Krystexxa

Pegloticase

arrow
DIA 2025
Not Confirmed

Brand Name : Krystexxa

arrow
DIA 2025
Not Confirmed

Pegloticase

Main Therapeutic Indication : Rheumatology

Currency : USD

2023 Revenue in Millions : 272

2022 Revenue in Millions : 0

Growth (%) : Acquired from Horizon

blank

02

Brand Name : Krystexxa

Pegloticase

arrow
DIA 2025
Not Confirmed

Brand Name : Krystexxa

arrow
DIA 2025
Not Confirmed

Pegloticase

Main Therapeutic Indication : Rheumatology

Currency : USD

2024 Revenue in Millions : 1,185

2023 Revenue in Millions : 272

Growth (%) : 336

blank